Intelligent tumor finding and introduction of linked medication

The short-term aims in the field of nanoparticle research include the development of new magnetic nanoparticles with increased heat development in the alternating magnetic field and the optimization of the primary coating of the nanoparticles for increased deposit stability in the tumor tissues. Both developments are supposed to significantly increase the treatment success and simultaneously further reduce the strain on the patient.

The goal of the long-term research efforts in the field of nanoparticles at MagForce is to adapt the NanoTherm^® therapy to systemic application. This means that in the future the nanoparticles will be interventionally introduced and then be able to find their way into the tumor on their own. Aside from the development of "intelligent" nanoparticles, MagForce also has been conducting research for some time into linking medications (drug delivery) to the iron oxide particles. This would mean that chemotherapeutic agents can be directly brought into the tumor and released there. This would reduce the damaging effects of chemotherapy, since the poisonous cargo would not have to go through the entire body before reaching its target.